Search Results - "Lera Ruiz, Manuel de"
-
1
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
Published in Cell host & microbe (08-04-2020)“…Artemisin combination therapy (ACT) is the main treatment option for malaria, which is caused by the intracellular parasite Plasmodium. However, increased…”
Get full text
Journal Article -
2
Histamine H3 Receptor as a Drug Discovery Target
Published in Journal of medicinal chemistry (13-01-2011)Get full text
Journal Article -
3
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
Published in Journal of medicinal chemistry (24-09-2015)“…The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today…”
Get full text
Journal Article -
4
Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption
Published in ChemMedChem (01-02-2015)“…Developing new antiretroviral therapies for HIV‐1 infection with potential for less frequent dosing represents an important goal within drug discovery. Herein,…”
Get full text
Journal Article -
5
Histamine H 3 Receptor as a Drug Discovery Target
Published in Journal of medicinal chemistry (13-01-2011)Get full text
Journal Article -
6
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
Published in Structure (London) (07-07-2022)“…Plasmepsins IX (PMIX) and X (PMX) are essential aspartyl proteases for Plasmodium spp. egress, invasion, and development. WM4 and WM382 inhibit PMIX and PMX in…”
Get full text
Journal Article -
7
Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3‑Fluoro-4-aminopiperidine
Published in Journal of organic chemistry (21-06-2019)“…A practical and efficient enantioselective synthesis of the calcitonin gene-related peptide receptor antagonist 1 has been developed. The key structural…”
Get full text
Journal Article -
8
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
Published in ACS medicinal chemistry letters (10-11-2022)“…Drug resistance to first-line antimalarialsincluding artemisininis increasing, resulting in a critical need for the discovery of new agents with novel…”
Get full text
Journal Article -
9
Careful Navigation of the Crystallographic Landscape of MK-8970: A Racemic Acetal Carbonate Prodrug of Raltegravir
Published in Organic process research & development (18-12-2015)“…MK-8970 is an acetal carbonate prodrug of raltegravir (Isentress). This work presents the Merck team’s investigations into the polymorphism of MK-8970, the…”
Get full text
Journal Article -
10
Stereoselective synthesis of highly functionalised P-stereogenic nucleosides via palladium-catalysed P–C cross-coupling reactions
Published in Tetrahedron letters (01-12-2008)“…We have shown that the configuration at the P-stereogenic centre in a range of H-phosphonates can be assigned using a combination of chromatographic mobility,…”
Get full text
Journal Article -
11
Exploration of conjugate addition routes to advanced tricyclic components of mangicol A
Published in Tetrahedron (12-06-2006)“…Two synthetic approaches to the cytotoxic marine natural product known as mangicol A are described. The starting material common to both pathways is the…”
Get full text
Journal Article -
12
Adenosine A2A Receptor as a Drug Discovery Target
Published in Journal of medicinal chemistry (08-05-2014)“…The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous…”
Get full text
Journal Article -
13
Invention of MK-7845, a SARS-CoV‑2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic
Published in Journal of medicinal chemistry (14-03-2024)“…As SARS-CoV-2 continues to circulate, antiviral treatments are needed to complement vaccines. The virus’s main protease, 3CLPro, is an attractive drug target…”
Get full text
Journal Article -
14
Adenosine A 2A Receptor as a Drug Discovery Target
Published in Journal of medicinal chemistry (08-05-2014)Get full text
Journal Article -
15
Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity
Published in Bioorganic & medicinal chemistry letters (01-11-2013)“…A novel series of non-imidazole bicyclic and tricyclic histamine H3 receptor antagonists has been discovered. Compound 17 was identified as a centrally…”
Get full text
Journal Article -
16
Evaluation of possible intramolecular [4+2] cycloaddition routes for assembling the central tetracyclic core of the potent marine antiinflammatory agent mangicol A
Published in Tetrahedron (29-05-2006)“…A plan for enantioselective construction of the mangicol A framework by means of intramolecular Diels–Alder cycloaddition is outlined. First to be assembled is…”
Get full text
Journal Article -
17
Cover Picture: Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption (ChemMedChem 2/2015)
Published in ChemMedChem (01-02-2015)Get full text
Journal Article